For patients with undiagnosed heart disease, taking drugs such as statins and beta blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.
New research from the Stanford University School of Medicine suggests that these preventive drugs can steer patients away from having a heart attack toward the less serious symptom of mild chest pain that occurs only with exercise (angina) even if they do not stop the build-up of cholesterol in their arteries. The study, published in the February 21 issue of the Annals of Internal Medicine, was conducted with investigators at Kaiser Permanente Division of Research in Oakland and the University of California-San Francisco.
"That's the scary thing about heart disease,""said senior author Mark Hlatky, professor of health research and policy and of cardiovascular medicine at Stanford. "You can be fine one minute and dead the next. You can put up with a little chest pain every once in a while if you know you're not about to die from it," he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze